A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute vs. Everolimus-Eluting Xience V in Real-World Patients: TWENTE
Presenter: C. Von Birgelen
Up Next
Presenter: Harald Rittger
More slides +
Presenter: Ted Feldman
Presenter: J. M. Sinning